Literature DB >> 20879866

Excess mortality for non–AIDS-defining cancers among people with AIDS.

Antonella Zucchetto1, Barbara Suligoi, Angela De Paoli, Simona Pennazza, Jerry Polesel, Silvia Bruzzone, Giovanni Rezza, Paolo De Paoli, Luigino Dal Maso, Diego Serraino.   

Abstract

During the period 1999–2006, non–AIDS-defining cancers accounted for 7.4% of deaths among Italian people with AIDS. The risk of death was 6.6-fold higher than in the general population, being particularly elevated for virus-related cancers. The study findings highlighted the importance of monitoring the cancer burden on mortality for people with AIDS.

Entities:  

Mesh：

Year:  2010        PMID： 20879866     DOI： 10.1086/656629

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer.

Authors:  David J Riedel; Kristen A Stafford; Aparna Vadlamani; Robert R Redfield
Journal:  AIDS Res Hum Retroviruses       Date:  2016-12-13       Impact factor: 2.205

2.  Outcomes of a Tailored Intervention for Cigarette Smoking Cessation Among Latinos Living With HIV/AIDS.

Authors:  Cassandra A Stanton; George D Papandonatos; Jonathan Shuter; Alexandra Bicki; Elizabeth E Lloyd-Richardson; Marcel A de Dios; Kathleen M Morrow; Solomon B Makgoeng; Karen T Tashima; Raymond S Niaura
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

3.  Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial.

Authors:  Jonathan Shuter; Daniela A Morales; Shannon E Considine-Dunn; Lawrence C An; Cassandra A Stanton
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

4.  Cervical cytology and histopathologic abnormalities in women living with AIDS in São Paulo, Brazil.

Authors:  Valdir Monteiro Pinto; Jonathan E Golub; Mariza Vono Tancredi; Rosa Souza Alencar; Angelica Espinosa Miranda
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08       Impact factor: 3.731

5.  HIV-associated lung cancer: ambiguities and challenges.

Authors:  James J Goedert
Journal:  AIDS       Date:  2012-05-15       Impact factor: 4.177

Review 6.  The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.

Authors:  Emanuela Vaccher; Diego Serraino; Antonino Carbone; Paolo De Paoli
Journal:  Oncologist       Date:  2014-06-26

7.  Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.

Authors:  Elena Raffetti; Laura Albini; Daria Gotti; Daniela Segala; Franco Maggiolo; Elisa di Filippo; Annalisa Saracino; Nicoletta Ladisa; Giuseppe Lapadula; Chiara Fornabaio; Filippo Castelnuovo; Salvatore Casari; Massimiliano Fabbiani; Piera Pierotti; Francesco Donato; Eugenia Quiros-Roldan
Journal:  BMC Public Health       Date:  2015-03-12       Impact factor: 3.295

8.  Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.

Authors:  Sang Hoon Han; Seung Up Kim; Chang Oh Kim; Su Jin Jeong; Jun Yong Park; Jun Yong Choi; Do Young Kim; Sang Hoon Ahn; Young Goo Song; Kwang-Hyub Han; June Myung Kim
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

9.  Developing clinical strength-of-evidence approach to define HIV-associated malignancies for cancer registration in Kenya.

Authors:  Anne Korir; Nathan Mauti; Pamela Moats; Matthew J Gurka; Geoffrey Mutuma; Christine Metheny; Peter M Mwamba; Peter O Oyiro; Melanie Fisher; Leona W Ayers; Rosemary Rochford; Walter O Mwanda; Scot C Remick
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Long-term CD4+ cell count in response to combination antiretroviral therapy.

Authors:  Paula M Luz; Beatriz Grinsztejn; Luciane Velasque; Antonio G Pacheco; Valdilea G Veloso; Richard D Moore; Claudio J Struchiner
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.